Cite
MLA Citation
Yuji Nozaki et al.. “Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis.” Modern rheumatology, vol. 30, no. 2, 2020, pp. 249–258. http://access.bl.uk/ark:/81055/vdc_100101889208.0x000023